Thursday, April 3, 2025
spot_img

Melexis: update on the share buy-back program

Press release – Regulated Information


Ieper, Belgium – 31 March 2025, 17.45 hrs CET

Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 34,000 Melexis shares on Euronext Brussels in the period from 24 to 28 March 2025.

Trade date Total shares purchased Average price (€) Min price (€) Max price (€) Buyback amount (€)
24/3/2025 6,000 56.83 56.10 57.10 340,987
25/3/2025 6,000 57.35 56.70 57.75 344,074
26/3/2025 7,000 56.06 55.70 57.30 392,392
27/3/2025 9,000 54.16 53.90 55.45 487,471
28/3/2025 6,000 53.53 53.10 54.50 321,167
TOTAL 34,000 55.47 53.10 57.75 1,886,090

As a result of purchases made since the launch of the share buy-back program for up to 850,000 shares, Melexis now holds 337,200 treasury shares.

Powered by SlickText.com

Hot this week

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

Topics

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT...

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre...
spot_img

Related Articles

Popular Categories

spot_img